95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.44%
Positive revenue growth while FSM is negative. John Neff might see a notable competitive edge here.
19.36%
Gross profit growth above 1.5x FSM's 8.83%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
12.09%
EBIT growth above 1.5x FSM's 4.74%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
12.09%
Operating income growth above 1.5x FSM's 4.74%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-46.04%
Negative net income growth while FSM stands at 65.54%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-46.15%
Negative EPS growth while FSM is at 55.75%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-46.15%
Negative diluted EPS growth while FSM is at 54.18%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.13%
Share reduction more than 1.5x FSM's 0.85%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.05%
Diluted share reduction more than 1.5x FSM's 1.88%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
7.81%
Positive OCF growth while FSM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
251.29%
Positive FCF growth while FSM is negative. John Neff would see a strong competitive edge in net cash generation.
20.66%
10Y revenue/share CAGR under 50% of FSM's 90.18%. Michael Burry would suspect a lasting competitive disadvantage.
51.97%
5Y revenue/share CAGR similar to FSM's 48.37%. Walter Schloss might see both companies benefiting from the same mid-term trends.
34.55%
3Y revenue/share CAGR under 50% of FSM's 69.57%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
0.77%
10Y OCF/share CAGR under 50% of FSM's 237.43%. Michael Burry would worry about a persistent underperformance in cash creation.
71.89%
5Y OCF/share CAGR at 50-75% of FSM's 97.18%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
75.55%
3Y OCF/share CAGR under 50% of FSM's 363.57%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-16.12%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
151.82%
5Y net income/share CAGR above 1.5x FSM's 5.79%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
170.60%
Below 50% of FSM's 537.55%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
80.17%
10Y equity/share CAGR at 50-75% of FSM's 145.68%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
24.93%
5Y equity/share CAGR at 50-75% of FSM's 45.47%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
19.74%
3Y equity/share CAGR at 50-75% of FSM's 26.83%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
118.73%
AR growth well above FSM's 29.63%. Michael Burry fears inflated revenue or higher default risk in the near future.
-15.06%
Inventory is declining while FSM stands at 6.37%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.76%
Asset growth 1.25-1.5x FSM's 1.90%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
1.46%
1.25-1.5x FSM's 1.00%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-6.09%
We’re deleveraging while FSM stands at 20.63%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
38.24%
SG&A growth well above FSM's 2.89%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.